Abstract: A sealed honeycomb structure which can suppress increase of pressure loss and improve durability favorably is disclosed. A sealed honeycomb structure 100 including includes a honeycomb structure having porous walls dividedly forming inlet cells and outlet cells, an outlet side sealing portion, and an inlet side sealing portion, wherein an opening area of the inlet cell is larger than an opening area of an outlet cell on a cross-section of the honeycomb structure, wherein at least one outlet cell is a reinforced cell where a reinforcing part for reinforcing the outlet cell is formed at at least one corner portion at which the walls on a cross-section vertical to an extending direction of the cell cross each other, and wherein the inlet cell is a non-reinforced cell where the reinforcing part is not formed at all the corner portions at which the walls on the cross-section vertical to the extending direction of the cell cross each other.

Abstract: The present invention relates to a composition for treating inflammatory brain diseases which includes a stem cell as an active ingredient. When the stem cell according to the present invention is directly administered to animal models with inflammatory brain diseases, a brain damage caused by inflammation such as edema is significantly reduced, the weight-loss phenomenon is greatly improved, and the like, and thus the cell has an excellent effect in treating inflammatory brain diseases and consequently can be used effectively in treating inflammatory brain diseases.

Abstract: A method and an apparatus for controlling regeneration of an exhaust emission control device in which a diesel particulate filter (DPF) may be installed at a back stage of a reducing agent supply apparatus may include measuring temperature of a front stage of the DPF at the time of supplying a reducing agent, comparing a temperature value measured at the front stage of the DPF with a temperature modeling value of the front stage of the DPF, and controlling the regeneration of the DPF by comparing a difference between the temperature value and the temperature modeling value with a reference variation.

Abstract: A sealed honeycomb structure may include porous walls dividedly forming inlet cells and outlet cells extending from an end surface of an inlet side to an end surface of an outlet side, inlet and outlet side sealing portion 5b, and an inlet side sealing portion, wherein at least one outlet cell is a reinforced cell where a reinforcing part 6 for reinforcing the outlet cell 2b is formed at at least one corner portion 21a at which the walls on a cross-section vertical to an extending direction of the cell cross each other, wherein the inlet cell is a non-reinforced cell where the reinforcing part is not formed at all the corner portions at which the walls on the cross-section vertical to the extending direction of the cell cross each other, and wherein the reinforcing parts 6 of the reinforced cells 22 are formed at a section of the honeycomb structure from the end surface of the outlet side in the extending direction of the cell.

Abstract: A sealed honeycomb structure which can suppress increase of pressure loss and improve durability favorably is disclosed. A sealed honeycomb structure 100 including includes a honeycomb structure having porous walls dividedly forming inlet cells and outlet cells, an outlet side sealing portion, and an inlet side sealing portion, wherein an opening area of the inlet cell is larger than an opening area of an outlet cell on a cross-section of the honeycomb structure, wherein at least one outlet cell is a reinforced cell where a reinforcing part for reinforcing the outlet cell is formed at at least one corner portion at which the walls on a cross-section vertical to an extending direction of the cell cross each other, and wherein the inlet cell is a non-reinforced cell where the reinforcing part is not formed at all the corner portions at which the walls on the cross-section vertical to the extending direction of the cell cross each other.

Abstract: A sealed honeycomb structure may include porous walls dividedly forming inlet cells and outlet cells extending from an end surface of an inlet side to an end surface of an outlet side, an outlet side sealing portion, and an inlet side sealing portion, wherein at least one outlet cell is a reinforced cell, where a reinforced part for reinforcing the outlet cell is formed at at least one corner portion at which the walls on a cross-section vertical to an extending direction of the cell cross each other, and wherein the inlet cell is a non-reinforced cell where the reinforced part is not formed at all the corner portions at which the walls on the cross-section vertical to the extending direction of the cell cross each other.

Abstract: Disclosed is a composition for the prophylaxis or therapy of intraventricular hemorrhage in preterm infants comprising mensenchymal stem cells. Functioning to prevent ventricular dilatation and reduce the level of inflammatory cytokines in cerebrospinal fluid, the composition comprising mesenchymal stem cells is advantageously useful for the prophylaxis or therapy of intraventricular hemorrhage in preterm infants. Accordingly, the composition is effectively preventive of hydrocephalus which occurs subsequent to intraventricular hemorrhage. In addition, the composition makes not only a histological and biochemical recuperation in the intraventricular hemorrhage-injured brain, but also significantly improves sensory motor functions. Mesenchymal stem cells can be used as an effective therapeutic agent because they are less prone to induce immune rejection responses and are highly likely to secrete proliferative, differentiative, and regulatory factors.

Abstract: There is provided a method of treating lung diseases including administering cells separated or proliferated from umbilical cord blood to a patient suffering from such diseases.

Abstract: The present invention relates to a composition comprising separated or proliferated cells from umbilical cord blood for treating developmental and/or chronic lung disease, more precisely a composition containing separated or proliferated cells from umbilical cord blood for intratracheal administration for treating developmental and/or chronic lung disease. The cells of the composition of the present invention have excellent activities of proliferation and differentiation, so that the extraction, separation and selection of a tissue donor are all very easy. Besides, the composition of the invention can be very effectively used for the treatment of developmental and/or chronic diseases by intratracheal administration.